Susquehanna International Group, LLP Genetic Technologies LTD Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.93 - $6.18 $42,687 - $283,668	45,901 Added 148.16%	76,881 $71,000
Q3 2022 Nov 14, 2022	SELL	$0.0 - $6.4 $0 - $132,627	-20,723 Reduced 40.08%	30,980 $37,000
Q2 2022 Aug 15, 2022	BUY	$0.0 - $0.01 $0 - $188	18,810 Added 57.19%	51,703 $59,000
Q1 2022 May 16, 2022	BUY	$0.0 - $0.0 $0 - $0	5,933 Added 22.01%	32,893 $65,000
Q4 2021 Feb 14, 2022	SELL	$0.0 - $0.01 $0 - $82	-8,212 Reduced 23.35%	26,960 $51,000
Q3 2021 Nov 15, 2021	SELL	$0.0 - $0.01 $0 - $153	-15,354 Reduced 30.39%	35,172 $108,000
Q2 2021 Aug 11, 2021	SELL	$0.0 - $0.02 $0 - $340	-17,001 Reduced 25.18%	50,526 $215,000
Q1 2021 May 17, 2021	SELL	$0.0 - $0.01 $0 - $79	-7,985 Reduced 10.57%	67,527 $282,000
Q4 2020 Feb 16, 2021	BUY	$0.0 - $0.0 $0 - $0	22,196 Added 41.63%	75,512 $272,000
Q3 2020 Nov 16, 2020	BUY	$0.0 - $0.0 $0 - $0	53,316 New	53,316 $184,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.